Immediate Impact
1 by Nobel laureates 2 from Science/Nature 51 standout
Citing Papers
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Works of Karina Jackson being referenced
British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009
2009
Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Karina Jackson | 589 | 615 | 180 | 192 | 21 | 1.0k | |
| Lars Erik Bryld | 701 | 734 | 120 | 230 | 33 | 1.2k | |
| Adele Clark | 908 | 495 | 148 | 317 | 22 | 1.2k | |
| Marc Bourcier | 707 | 702 | 119 | 82 | 42 | 1.2k | |
| Ines Schaefer | 430 | 350 | 139 | 93 | 16 | 895 | |
| Ian Landells | 563 | 723 | 158 | 69 | 38 | 1.2k | |
| R. You | 791 | 1161 | 170 | 35 | 17 | 1.3k | |
| Ines Schäfer | 453 | 357 | 64 | 102 | 50 | 881 | |
| Grażyna Pulka | 752 | 310 | 469 | 556 | 33 | 1.2k | |
| Yin You | 456 | 953 | 123 | 29 | 33 | 1.1k | |
| Stefanie Rosumeck | 854 | 480 | 64 | 32 | 37 | 1.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...